Clinic Policy and Retention in Methadone Maintenance

References

• Allison M., Hubbard R. L. Drag abuse treatment process: A review of the literature. Int. J. Addict. 1985; 20: 1321–1345
   PubMed Web of Science ®Google Scholar
• Bale R. N., Van Stone W. W., Kuldau J. M., Engelsing T. M. J., Elashoff R. M., Zarcone V. P. Therapeutic communities vs methadone maintenance. Arch. Gen. Psychiatry 1980; 37: 179–193
   PubMed Web of Science ®Google Scholar
• Ball J. C., Lange R., Myers C. P., Friedman S. R. Reducing the risk of AIDS through methadone maintenance treatment. J. Health Soc. Behav. 1988; 29: 214–226
   PubMed Web of Science ®Google Scholar
• Bell J., DiGiusto E., Byth K. Who should receive methadone maintenance. Br. J. Addict. 1992a; 87: 689–694
   PubMedGoogle Scholar
• Bell J., Hall W., Byth K. Changes in criminal activity after entering methadone maintenance. Br. J. Addict. 1992b; 87: 251–258
   PubMedGoogle Scholar
• Blix O., Grönbladh L. AIDS and IV Heroin Addicts: The Preventive Effect of Methadone Maintenance in Sweden. Psychiatric Research Center, University of Uppsala., Uppsala 1988
   Google Scholar
• Caplehorn J. R. M. An argument for the medical control of supply of drugs to addicts. Drug Alcohol Rev. 1990a; 9: 351–360
   PubMedGoogle Scholar
• Caplehorn J. R. M. Methadone Dosage and Retention in Maintenance Treatment. Department of Public Health, University of Sydney. 1990b, Unpublished Master's Treatise
   Google Scholar
• Caplehorn J. R. M., Batey R. G. Methadone maintenance in Australia. J. Drug Issues. 1992; 22: 661–678
   Web of Science ®Google Scholar
• Caplehorn J. R. M., Bell J. Methadone dosage and retention of patients in maintenance treatment. Med. J. Aust. 1991; 154: 195–199
   PubMed Web of Science ®Google Scholar
• Caplehorn J. R. M., Bell J., Kleinbaum D. G., Gebski V. J. Methadone dose and heroin use during maintenance treatment. Br. J. Addict. 1992, In press
   Google Scholar
• Cole S. G., Watterson O. A treatment typology for drug abuse in the DARP: 1971–1972 admissions. The Effectiveness of Drug Abuse Treatment, S. B. Sells, D. D. Simpson. Ballinger, Cambridge, Massachusetts 1976; III: 201–252.
   Google Scholar
• Corty E., Ball J. C. Admissions to methadone maintenance: Comparisons between programs and implications for treatment. J. Substance Abuse Treatment 1987; 4: 181–187
   PubMed Web of Science ®Google Scholar
• Cox D. R. Regression models and life-tables. J. R. Stat. Soc., B 1972; 34: 187–202
   Google Scholar
• Dole V. P., Joseph H. Methadone maintenance: Outcome after termination. N. Y. State J. Med. 1977; 77: 1409–1412
   PubMedGoogle Scholar
• Dole V. P., Joseph H. Long-term outcome of patients treated with methadone maintenance. Ann. N. Y. Acad. Sci. 1978; 311: 181–189
   PubMedGoogle Scholar
• Dole V. P., Nyswander M. Rehabilitation of patients on methadone programs. Proceedings of the 5th National Conference on Methadone. National Association for the Prevention of Addiction to Narcotics, New York 1973; 1–7
   Google Scholar
• Fisher D. G., Anglin M. D. Survivial analysis in drug program evaluation, Part i: Overall program effectiveness. Int. J. Addict. 1987; 22: 115–134
   PubMed Web of Science ®Google Scholar
• Foy A., Drinkwater V., White A. A prospective clinical audit of methadone maintenance therapy at The Royal Newcastle Hospital. Med. J. Aust. 1990; 151: 332–337
   Web of Science ®Google Scholar
• Garbutt G. D., Goldstein A. Blind comparison of three methadone maintenance dosages in 180 patients. In. Proceedings of the 4th National Conference on Methadone. National Association for the Prevention of Addiction to Narcotics, New York 1972; 411–414
   Google Scholar
• Gearing F. R., Schweitzer M. D. An epidemiologic evaluation of long-term methadone maintenance treatment for heroin addiction. Am. J. Epidemiol. 1974; 100: 101–112
   PubMed Web of Science ®Google Scholar
• Gorsuch R. L., Abbamonte M., Sells S. B. Evaluation of treatments for drug users in the DARP: 1971–1972 admissions. Retention in treatment. The Effectiveness of Drug Abuse Treatment: Evaluation of Treatment Outcomes for 1971–1972 DARP Admission Cohort, S. B. Sells, D. D. Simpson. Ballinger, Cambridge, Massachusetts 1976; IV: 29–39.
   Google Scholar
• Gunne L., Grönbladh L. The Swedish methadone maintenance program: A controlled study. Drug Alcohol Depend. 1981; 7: 249–256
   PubMed Web of Science ®Google Scholar
• Hall S. M. Methadone treatment: A review of the research findings. Research on the Treatment of Narcotic Addiction: State of the Art, J. R. Cooper, F. Altman, B. S. Brown, D. Czechowicz. National Institute on Drug Abuse, Rockville, Maryland 1983; 575–632.
   Google Scholar
• Hargreaves W. A. Methadone dose and duration for maintenance treatment. Research on the Treatment of Narcotic Addiction: State of the Art, J. R. Cooper, F. Altman, B. S. Brown, D. Czechowicz. National Institute on Drug Abuse, Rockville, Maryland 1983; 19–79.
   Google Scholar
• Harrell F. E., Lee K. L. (1986) Verifying assumptions of the Cox proportional hazards model. In. Proceedings of the Eleventh Annual SAS Users Group International Conference, Atlanta, February, 9–121986. SAS Institute, Cary, North Carolina, 823–828
   Google Scholar
• Jaffe J. H. Further experience with methadone in the treatment of narcotics users. Int. J. Addict. 1970; 5: 375–389
   PubMed Web of Science ®Google Scholar
• Joe G. W. Studies of retention in treatment of drug users in the DARP: 1969–1971 admissions. Introduction and analysis of termination rates and retention in treatment in relation to patient type and treatment type. Evaluation of Treatments, S. B. Sells. Ballinger., Cambridge, Massachusetts 1976; I: 441–478.
   Google Scholar
• Joseph H., Dole V. P. () Methadone patients on probation and parole. Fed. Probat. 1970; 34: 42–48
   Google Scholar
• Kalbfleisch J. D., Prentice R. L. The Statistical Analysis of Failure Time Data. Wiley., New York 1980
   Google Scholar
• Kleinbaum D. G., Kupper L. L., Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. Van Nostrand Reinhold, New York 1982
   Google Scholar
• Lambert M. J. The individual therapist's contribution to psychotherapy process and outcome. Clin. Psychol. Rev. 1989; 9: 469–485
   Web of Science ®Google Scholar
• Ling W., Charuvastra C., Kaim S. C., Klett C. J. Methadyl acetate and methadone as maintenance treatments for heroin addicts: A Veterans Administration cooperative study. Arch. Gen. Psychiatry 1976; 33: 709–720
   PubMed Web of Science ®Google Scholar
• Luborsky L., McLellan A. T., Woody G. E., O'Brien C. P., Auerbach A. Therapist success and its deteminants. Arch. Gen. Psychiatry. 1985; 42: 602–611
   PubMed Web of Science ®Google Scholar
• McGlothlin W. H., Anglin M. D. Long-term follow-up of clients of high-and low-dose methadone programs. Arch. Gen. Psychiatry 1981; 38: 1055–1063
   PubMed Web of Science ®Google Scholar
• McLellan A. T. Patient characteristics associated with outcome. Research on the Treatment of Narcotic Addiction: State of the Art, J. R. Cooper, F. Altman, B. S. Brown, D. Czechowicz. National Institute on Drug Abuse, Rockville, Maryland 1983; 500–529.
   Google Scholar
• McLellan A. T., Woody G. E., Luborsky L., Goehl L. Is the counselor an “active ingredient” in substance abuse rehabilitation? An examination of treatment success among four counselors. J. Nerv. Ment. Dis. 1988; 176: 423–430
   PubMed Web of Science ®Google Scholar
• Newman R. C., Whitehill W. B. Double-bind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong. Lancet 1979; ii: 485–488
   Google Scholar
• Novick D. M., Joseph H., Croxson S., Salsitz E. A., Wang G., Richman B. L., Poretsky L., Keefe J. B., Whimbey E. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. Arch. Intern. Med. 1990; 150: 97–99
   PubMed Web of Science ®Google Scholar
• Parloff M. B., Waskow I. E., Wolfe B. E. Research on therapist variables in relation to process and outcome. Handbook of Psychotherapy and Behavior Change: An Empirical Analysis, S. L. Garfield, A. E. Bergin. Wiley, New York 1978; 233–282.
   Google Scholar
• Perkins M. E., Bloch M. A. A study of some failures in methadone treatment. Am. J. Psychiatry 1971; 128: 47–51
   PubMed Web of Science ®Google Scholar
• Rezza G., Oliva C., Sasse H. Preventing AIDS among Italian Drug Addicts: Evaluation of Treatment Programs and Informative Strategies. Presented at the 3rd International Conference on AIDS, StockholmSweden, 1988, Abstract 8531
   Google Scholar
• Rosenbaum M. A matter of style: Variation among methadone clinics in the control of clients. Contemp. Drug Probl. 1985; 12: 375–399
   Google Scholar
• Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982; 69: 239–241
   Web of Science ®Google Scholar
• Simpson D. D., Joe G. W., Lehman W. E. K., Sells S. B. Addiction careers: Etiology, treatment, and 12-year follow-up outcomes. J. Drug Issues 1986; 16: 107–121
   Web of Science ®Google Scholar
• Stimmel B., Goldberg J., Cohen M., Rotkopf E. Detoxification from methadone maintenance: Risk factors associated with relapse to narcotic use. Ann. N. Y. Acad. Med. 1978; 311: 173–180
   PubMedGoogle Scholar
• Szapocznik J., Ladner R. Factors related to successful retention in methadone maintenance: A review. Int. J. Addict. 1977; 12: 1067–1085
   PubMed Web of Science ®Google Scholar